NCT07094802View on ClinicalTrials.gov

Comparison of Intrathecal Bupivacaine With and Without Morphine for Post-operative Analgesia in Parturients Undergoing Elective Cesarean Section: A Randomized Controlled Trial

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

October 15, 2025

Primary Completion Date

March 20, 2026

Study Completion Date

August 15, 2026

Conditions
Postoperative PainCesarean DeliveryAnalgesia, Obstetrical
Interventions
DRUG

Intrathecal morphine with bupivacaine

Participants will receive 100 mcg intrathecal morphine along with 2.2ml of 0.5% hyperbaric bupivacaine

DRUG

Hyperbaric Bupivicaine

0.5% hyperbaric Bupivacaine 2.2 ml

All Listed Sponsors
lead

Tribhuvan University Teaching Hospital, Institute Of Medicine.

OTHER